• Profile
Close

Tobacco use and prevalence of human papillomavirus in self-collected cervicovaginal swabs between 2009 and 2014

Obstetrics and Gynecology Jul 04, 2018

Tarney CM, et al. - In this large cross-sectional, population-based study, the relationships between an objective biomarker of current tobacco exposure and high-risk genital human papillomavirus (HPV) prevalence were evaluated among adult women in the United States. Researchers identified increased odds of infection with high-risk genital HPV in association with cigarette smoking and exposure to secondhand smoke. This association was noted to be independent of lifetime number of sexual partners.

Methods

  • Using three consecutive 2-year cycles (2009–2014) from the cross-sectional National Health and Nutrition Examination Surveys, a retrospective analysis of adult women (aged 18–59 years) was performed.
  • Inclusion of women who provided self-collected cervicovaginal swabs and serum was done.
  • Using a Linear Array HPV assay, researchers conducted human papillomavirus genotyping on cervicovaginal samples.
  • To provide a biomarker of recent tobacco exposure, they assayed cotinine (a major metabolite of nicotine) from serum.
  • Based on serum cotinine concentration levels, they stratified participants into three levels of tobacco exposure (nonsmokers, secondhand smoke exposure, and smokers) using previously published ethnic-specific cut points.
  • They provided weighted percentages to account for unequal selection probabilities among participants and adjustments for nonresponse.

Results

  • Researchers analyzed 5,158 women.
  • Of these, 2,778 were classified as nonsmokers (57.1%, 95% CI 54.5–59.6%), 1,109 classified as having secondhand smoke exposure (18.4%, 95% CI 16.5–20.3%), and 1,271 classified as smokers (24.6%, 95% CI 22.8–26.5%) using serum cotinine concentration levels.
  • Nicotine exposure groups differed regarding prevalence of HPV infection (P<.001): 441 smokers (32.1%, 95% CI 29.6–34.7%), 322 women with secondhand smoke exposure (26.1%, 95% CI 22.7–29.7%), and 451 nonsmokers (15.1%, 95% CI 13.3–17.1%) had a high-risk genital HPV infection.
  • Compared with nonsmokers, risks for infection with a high-risk HPV genotype for smokers (adjusted odds ratio [OR] 1.7, 95% CI 1.4–22) and secondhand smokers (adjusted OR 1.4, 95% CI 1.1–1.8) are similarly increased (P<.001) controlling for demographics and number of lifetime sexual partners.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay